Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007
- PMID: 21963582
- DOI: 10.1097/CCM.0b013e318232db65
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007
Erratum in
- Crit Care Med. 2012 Oct;40(10):2932
Abstract
Objectives: To assess trends in number of hospitalizations, outcomes, and costs of severe sepsis in the United States.
Design: Temporal trends study using the Nationwide Inpatient Sample.
Patients: Adult patients with severe sepsis (defined as a diagnosis of sepsis and organ dysfunction) diagnosed between 2003 and 2007.
Measurements and main results: We determined the weighted frequency of patients hospitalized with severe sepsis. We calculated age- and sex-adjusted population-based mortality rates for severe sepsis per 100,000 population and also used logistic regression to adjust in-hospital mortality rates for patient characteristics. We calculated inflation-adjusted costs using hospital-specific cost-to-charge ratios. We identified a rapid steady increase in the number of cases of severe sepsis, from 415,280 in 2003 to 711,736 in 2007 (a 71% increase). The total hospital costs for all patients with severe sepsis increased from $15.4 billion in 2003 to $24.3 billion in 2007 (57% increase). The proportion of patients with severe sepsis and only a single organ dysfunction decreased from 51% in 2003 to 45% in 2007 (p < .001), whereas the proportion of patients with three or four or more organ dysfunctions increased 1.19-fold and 1.51-fold, respectively (p < .001). During the same time period, we observed 2% decrease per year in hospital mortality for patients with severe sepsis (p < .001), as well as a slight decrease in the length of stay (9.9 days to 9.2 days; p < .001) and a significant decrease in the geometric mean cost per case of severe sepsis ($20,210 per case in 2003 and $19,330 in 2007; p = .025).
Conclusions: The increase in the number of hospitalizations for severe sepsis coupled with declining in-hospital mortality and declining geometric mean cost per case may reflect improvements in care or increases in discharges to skilled nursing facilities; however, these findings more likely represent changes in documentation and hospital coding practices that could bias efforts to conduct national surveillance.
Similar articles
-
Nationwide trends of severe sepsis in the 21st century (2000-2007).Chest. 2011 Nov;140(5):1223-1231. doi: 10.1378/chest.11-0352. Epub 2011 Aug 18. Chest. 2011. PMID: 21852297
-
What is the best method for estimating the burden of severe sepsis in the United States?J Crit Care. 2012 Aug;27(4):414.e1-9. doi: 10.1016/j.jcrc.2012.02.004. Epub 2012 Apr 17. J Crit Care. 2012. PMID: 22516143
-
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.Crit Care. 2004 Oct;8(5):R291-8. doi: 10.1186/cc2893. Epub 2004 Jul 5. Crit Care. 2004. PMID: 15469571 Free PMC article.
-
Trends and Characteristics of Hospitalizations in Patients With Heart Transplant.Curr Probl Cardiol. 2022 Aug;47(8):101210. doi: 10.1016/j.cpcardiol.2022.101210. Epub 2022 Apr 20. Curr Probl Cardiol. 2022. PMID: 35460682 Review.
-
[The cost of sepsis].Anaesthesist. 2006 Jun;55 Suppl 1:36-42. doi: 10.1007/s00101-006-1039-y. Anaesthesist. 2006. PMID: 16685555 Review. German.
Cited by
-
The Global Burden of Sepsis and Septic Shock.Epidemiologia (Basel). 2024 Jul 25;5(3):456-478. doi: 10.3390/epidemiologia5030032. Epidemiologia (Basel). 2024. PMID: 39189251 Free PMC article. Review.
-
Macrophage biomimetic nanoparticle-targeted functional extracellular vesicle micro-RNAs revealed via multiomics analysis alleviate sepsis-induced acute lung injury.J Nanobiotechnology. 2024 Jun 23;22(1):362. doi: 10.1186/s12951-024-02597-z. J Nanobiotechnology. 2024. PMID: 38910259 Free PMC article.
-
Initial Care for Patients with Severe Sepsis and Septic Shock: The Next ICU Quality Measure.Hosp Pharm. 2016 Jan;51(1):19-25. doi: 10.1310/hpj5101-19. Epub 2016 Jan 1. Hosp Pharm. 2016. PMID: 38745719 Free PMC article.
-
Carbon monoxide-induced autophagy enhances human mesenchymal stromal cell function via paracrine actions in murine polymicrobial sepsis.Mol Ther. 2024 Jul 3;32(7):2232-2247. doi: 10.1016/j.ymthe.2024.05.018. Epub 2024 May 11. Mol Ther. 2024. PMID: 38734903
-
Determining the Association Between the Origin of Sepsis and the Severity of Sepsis in Intensive Care Unit (ICU) Patients Using Acute Physiology and Chronic Health Evaluation (APACHE) IV.Cureus. 2024 Feb 21;16(2):e54653. doi: 10.7759/cureus.54653. eCollection 2024 Feb. Cureus. 2024. PMID: 38523937 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
